Alkermes ALKS
NASDAQ ALKS
$44.11 +1.14 (+2.65%)
At close: Oct 20, 2026 · 4:00 PM EDT

Alkermes (ALKS) Long-Term Debt Issuances (2013 - 2026)

Updated

Alkermes (ALKS) posted Long-Term Debt Issuances of $1.51 billion for Q1 2026.

Analysis

Alkermes (ALKS) Long-Term Debt Issuances (2013 - 2026) Analysis & Trends

For FY2021, Alkermes' Long-Term Debt Issuances came in at $23.57 million.

  • The Q1 2026 figure stands as the lowest quarterly Long-Term Debt Issuances since Q1 2021.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) LT Debt Issuance (Qtr)
1 Eli Lilly 1,146.94 Bn 1,115.53 Bn 19.71 Bn 8.94 Bn
2 Johnson & Johnson 624.96 Bn 543.49 Bn 17.26 Bn -
3 AbbVie 510.15 Bn 483.27 Bn 12.70 Bn -
4 Merck 366.13 Bn 320.51 Bn 12.21 Bn -
5 Novartis Ag 297.75 Bn 261.74 Bn 11.24 Bn 1.98 Bn
6 Astrazeneca 261.93 Bn 235.62 Bn 12.86 Bn -
7 Amgen 236.51 Bn 191.91 Bn 7.24 Bn -
8 Gilead Sciences 194.27 Bn 168.47 Bn 6.22 Bn -
9 Pfizer 171.74 Bn 118.39 Bn 10.94 Bn -
10 Alkermes 7.37 Bn 4.50 Bn 397.90 Mn -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2026 1.51 Bn
Mar 31, 2021 23.57 Mn
Mar 31, 2013 -2.07 Mn
API Access

Alkermes Long-Term Debt Issuances API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=long-term-debt-issuances&ticker=ALKS&period=max&api_key=YOUR_API_KEY